Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy

Rheumatology

Volumn 50, Issue 10, 2011, Pages 1927-1928

  Joannides, Alexis J ^a   El Shaboury, Hamid ^a   Guirguis, Roshdy ^b   Fasler, Julian J ^a   Rajagopal, Vivek ^a,b  

^a Department of Medicine ^*  (United Kingdom)

^b WEST SUFFOLK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCIUM; FOLIC ACID; HEMOGLOBIN; IRON; LERCANIDIPINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OLMESARTAN; OMEPRAZOLE; PAMIDRONIC ACID; SIMVASTATIN;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; BONE BIOPSY; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DECREASED APPETITE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FOLLOW UP; FRACTURE; GASTROSCOPY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IRON THERAPY; LETHARGY; LETTER; LIMB WEAKNESS; LYMPHADENOPATHY; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; MALE; METHOTREXATE ASSOCIATED LYMPHOPROLIFERATIVE DISORDER; NORMOCHROMIC NORMOCYTIC ANEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WEIGHT REDUCTION;

AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; METHOTREXATE; NEOPLASMS, UNKNOWN PRIMARY; PLEURAL EFFUSION; WITHHOLDING TREATMENT;

EID: 80053142477     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker214     Document Type: Letter

References (3)

1. Harris NL, Sverdlow SH. Methotrexate-associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardinam JW, eds. WHO classification of tumours. Pathology and genetics: tumours of haematopoietic and lymphoid tissues. 1st edition. Lyon, France: IARC Press, 2001:270-1.
2. Rizzi R, Curci P, Delia M et al. Spontaneous remission of "methotrexate-associated lymphoprolierative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 2009;26:1-9.
3. Hoshida Y, Xu J, Fujita S et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate indication. J Rheum 2007;34:322-30.